Open Government Portal

Found 10 records similar to Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic

Federal

High-level description of when patients, practitioners and pharmacists are exempt from some sections of the Controlled Drugs and Substances Act during the COVID-19 (coronavirus) pandemic.

Last Updated: Jan. 6, 2021
Date Published: Aug. 12, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, 56(1) class exemption, Controlled Drugs and Substances Act, CDSA, patients, practitioners, pharmacists, prescriptions
Federal

Health Canada's interpretation of controlled substances prescribing activities pharmacists can perform under the Controlled Drugs and Substances Act.

Last Updated: Mar. 25, 2021
Date Published: Apr. 21, 2020
Organization: Health Canada
Formats: HTML
Keywords:  56(1) class exemption, Controlled Drugs and Substances Act, CDSA, pharmacists, prescriptions, controlled substance, prescribing activities, adjusting formulation, doses
Federal

The following directive is intended to establish realistic minimum security standards for the storage of controlled substances as defined in the Controlled Drugs and Substances Act (CDSA), and drugs containing cannabis as defined in the Cannabis Regulations, which are flexible enough to take into consideration advances in technology, changes in the legal and illegal drug marketplace, building codes, construction materials and construction expertise.

Last Updated: Jun. 28, 2022
Date Published: Jul. 11, 2018
Organization: Health Canada
Formats: HTML
Keywords:  physical security requirements, Directive on physical-security-requirements, controlled substances, drugs, cannabis, drugs containing cannabis
Federal

Pursuant to section 56 of the CDSA and subject to the terms and conditions set out herein, Designated Persons are exempted from the application of following provisions of the CDSA, the Narcotic Control Regulations (NCR) and the ACMPR.

Last Updated: Jun. 27, 2022
Date Published: Mar. 1, 2018
Organization: Health Canada
Formats: HTML
Keywords:  class exemption, prohibitions to possess, produce medical-cannabis, medical-cannabis for medical-purposes, exemption for designated-persons, section-56 of CDSA
Federal

Pursuant to section 56 of the CDSA and subject to the terms and conditions set out herein, the Registered Persons are exempted from the application of following provisions of the CDSA, the Narcotic Control Regulations (NCR) and the ACMPR.

Last Updated: Jun. 27, 2022
Date Published: Mar. 1, 2018
Organization: Health Canada
Formats: HTML
Keywords:  class exemption, prohibitions to possess, produce medical-cannabis, medical-cannabis for medical-purposes, exemption for registered-persons, section-56 of CDSA
Federal

Pursuant to section 56 of the CDSA and subject to the terms and conditions set out herein, Registered Persons are exempted from the application of the following subsections of the CDSA, the Narcotic Control Regulations (NCR) and the ACMPR.

Last Updated: Jun. 27, 2022
Date Published: Mar. 1, 2018
Organization: Health Canada
Formats: HTML
Keywords:  class exemption, prohibitions to possess, produce medical-cannabis, medical-cannabis for medical-purposes, exemption for registered-persons-with-a-designated-person, section-56 of CDSA
Federal

Between 2018 and 2020, Health Canada has issued a number of exemptions to the Controlled Drugs and Substances Act. Some of the exemptions have been issued to maintain Canadians' access to controlled substances during the COVID-19 pandemic.

Last Updated: Jan. 6, 2021
Date Published: Jul. 16, 2020
Organization: Health Canada
Formats: HTML
Keywords:  COVID-19, pandemic, controlled substances, Controlled Drugs and Substances Act, relevant exemptions
Federal

Learn how and why we regulate controlled substances and their precursors.

Last Updated: Apr. 27, 2021
Date Published: Jan. 31, 2019
Organization: Health Canada
Formats: HTML
Keywords:  Guide, regulating Controlled Substances, precursors
Federal

Pursuant to section 56 of the CDSA and subject to the terms and conditions set out herein, applicants for a producer’s licence are exempted from the requirement in paragraph 33(1)(h) to provide a detailed description of security measures determined in accordance with the Security Directive in respect of the storage of cannabis and from the application of paragraph 33(1)(h) of the ACMPR in respect of the proposed security measures that apply in respect of the areas where cannabis plants are cultivated, propagated, harvested or trimmed and to the areas where cannabis seeds are present or stored.

Last Updated: Jun. 27, 2022
Date Published: Jan. 30, 2018
Organization: Health Canada
Formats: HTML
Keywords:  Section-56 Class Exemption, access-to-cannabis for medical-purposes, cannabis regulations, physical security requirements, applicants for licence-to-produce-cannabis, producer’s licence, exempted from requirements, paragraph 33(1)(h), description of security-measures
Federal

As the number of extreme heat events in Canada increases each year due to climate change, pharmacists and pharmacy technicians can expect an increase in heat-related illnesses across the country.

Last Updated: Oct. 31, 2022
Date Published: Jun. 16, 2021
Organization: Health Canada
Formats: HTML
Keywords:  climate change, extreme heat, extreme heat events, human health, heat-related illnesses, pharmacists and pharmacist-technicians
Date modified: